FB2024_04 , released June 25, 2024
Human Disease Model Report: mitochondrial DNA depletion syndrome 9
Open Close
General Information
Name
mitochondrial DNA depletion syndrome 9
FlyBase ID
FBhh0001036
Overview

This report describes mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), which shows autosomal recessive inheritance. The human gene implicated in this disease is succinate-CoA ligase alpha subunit (SUCLG1).

There is a high-ranking ortholog of SUCLG1 in Drosophila, Scsα1, along with a moderately-ranking ortholog, Scsα2, which is expressed almost exclusively in testis. Multiple alleles have been generated for Scsα1, including RNAi targeting constructs, hypomorphic and amorphic alleles, and insertion lines.

The human gene SUCLG1 has not been introduced into flies.

Drosophila mutants with a CRISPR-genereated knockout of Scsα1 have elevated levels of succinyl-CoA, a substrate of Scsα1, as well as other glycolysis and TCA cycle metabolites. Mutants also showed developmental delay, decreased locomotor activity, and reduced survival under starvation conditions.

[updated May 2019 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: mitochondrial DNA depletion syndrome
Symptoms and phenotype

Mitochondrial DNA (mtDNA) depletion syndrome (MDS) is a clinically heterogeneous group of mitochondrial disorders characterized by a reduction of the mtDNA copy number in affected tissues without mutations or rearrangements in the mtDNA. MDS is phenotypically heterogeneous, and can affect a specific organ or a combination of organs, with the main presentations described being either hepatocerebral (i.e. hepatic dysfunction, psychomotor delay), myopathic (i.e. hypotonia, muscle weakness, bulbar weakness), encephalomyopathic (i.e. hypotonia, muscle weakness, psychomotor delay) or neurogastrointestinal (i.e gastrointestinal dysmotility, peripheral neuropathy). [http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=GB&Expert=35698.0 2016.11.23]

Specific Disease Summary: mitochondrial DNA depletion syndrome 9
OMIM report

[MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA); MTDPS9](https://omim.org/entry/245400)

Human gene(s) implicated

[SUCCINATE-CoA LIGASE, GDP/ADP-FORMING, SUBUNIT ALPHA; SUCLG1](https://omim.org/entry/611224)

Symptoms and phenotype

Three patients with SUCLG1 mutations had an extremely severe phenotype with antenatal manifestations of the disorder, severe acidosis with lactic aciduria in the first day of life and death within 2-4 days. Liver histology in a patient with a SUCLG1 mutation showed steatosis. Muscle histology showed severe lipid accumulation. (adapted from Ostergaard 2008, pubmed:18392745)

Mitochondrial DNA depletion syndrome 9 is a severe autosomal recessive disorder characterized by infantile onset of hypotonia, lactic acidosis, severe psychomotor retardation, progressive neurologic deterioration, and excretion of methylmalonic acid. Some patients die in early infancy (summary by Rouzier et al., 2010, pubmed:20693550). [from MIM:245400, 2019.05.17]

Genetics

SUCLG1 was identified as a likely candidate gene after performing a genomewide search for homozygosity in two siblings from a small consanguineous family with three affected children. (adapted from Ostergaard 2008, pubmed:18392745)

In a consanguineous family with a history of mitochondrial DNA depletion syndrome 9, DNA sequencing revealed a homozygous 2-bp deletion in SUCLG1, a gene that encodes the alpha subunit of the Krebs cycle enzyme succinate-coenzyme A ligase (SUCL; Ostergaard et al. 2007, pubmed:17668387). The mtDNA depletion was thought to be explained by decreased mitochondrial nucleoside diphosphate kinase (NDPK) activity resulting from the inability of NDPK to form a complex with SUCL. [from MIM:245400, 2019.05.17]

Cellular phenotype and pathology

Analysis of mitochondrial protein in muscle and liver by blue native PAGE (BN-PAGE) showed a decreased amount of fully assembled complexes I, III, and IV. The amount of complex V was normal in muscle and increased in liver. The amount of complex II, which is encoded only by nuclear genes, was normal. (Ostergaard et al. 2007, pubmed:17668387)

Molecular information

In humans: Succinyl-CoA synthetase/ligase (SCS) is a mitochondrial enzyme that catalyzes the reversible process from succinyl-CoA to succinate and free coenzyme A in TCA cycle. SCS is a heterodimeric enzyme composed of an invariant α subunit encoded by SUCLG1 and a β subunit that determines the enzyme's nucleotide specificity: the GTP-specific β subunit encoded by SUCLG2 and the ATP-specific β subunit encoded by SUCLA2. (Quan et al. 2017, FBrf0234532.)

External links
Disease synonyms
lactic acidosis, fatal infantile
mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)
MTDPS9
Ortholog Information
Human gene(s) in FlyBase
    Human gene (HGNC)
    D. melanogaster ortholog (based on DIOPT)
    Comments on ortholog(s)

    One human gene to many Drosophila genes; 1 human to 2 Drosophila.

    Other mammalian ortholog(s) used
      D. melanogaster Gene Information (1)
      Gene Groups / Pathways
      Comments on ortholog(s)

      High-ranking ortholog of SUCLG1.

      Orthologs and Alignments from DRSC
      DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (1 groups)
        protein-protein
        Interacting group
        Assay
        References
        anti tag coimmunoprecipitation, Identification by mass spectrometry
        Alleles Reported to Model Human Disease (Disease Ontology) (0 alleles)
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        amorphic allele - molecular evidence
        CRISPR/Cas9
        References (5)